260 related articles for article (PubMed ID: 15694697)
1. Pathogenesis and etiology of essential hypertension: role of dietary carbohydrate.
Kopp W
Med Hypotheses; 2005; 64(4):782-7. PubMed ID: 15694697
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of hypertension in the cardiometabolic syndrome.
Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
[TBL] [Abstract][Full Text] [Related]
3. Insulin and the sympathetic nervous system in the pathophysiology of hypertension.
Landsberg L
Blood Press Suppl; 1996; 1():25-9. PubMed ID: 9162434
[TBL] [Abstract][Full Text] [Related]
4. [Hyperinsulinism/insulin resistance: cause, effect or marker of essential arterial hypertension?].
Greco D; Sinagra D
G Ital Cardiol; 1995 Feb; 25(2):207-16. PubMed ID: 7642026
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance, hyperinsulinemia and hypertension.
Weidmann P; de Courten M; Böhlen L
J Hypertens Suppl; 1993 Dec; 11(5):S27-38. PubMed ID: 8158379
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of insulin resistance in hypertensive rats.
Shimamoto K; Ura N
Clin Exp Hypertens; 2006 Aug; 28(6):543-52. PubMed ID: 16893759
[TBL] [Abstract][Full Text] [Related]
7. Interactions between insulin and sodium homeostasis in essential hypertension.
Semplicini A; Ceolotto G; Massimino M; Valle R; Serena L; De Toni R; Pessina AC; Dal Palù C
Am J Med Sci; 1994 Feb; 307 Suppl 1():S43-6. PubMed ID: 8141164
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of obesity-related hypertension: role of insulin and the sympathetic nervous system.
Landsberg L
J Cardiovasc Pharmacol; 1994; 23 Suppl 1():S1-8. PubMed ID: 7519690
[TBL] [Abstract][Full Text] [Related]
10. Microvascular dysfunction: causative role in the association between hypertension, insulin resistance and the metabolic syndrome?
Serné EH; de Jongh RT; Eringa EC; Ijzerman RG; de Boer MP; Stehouwer CD
Essays Biochem; 2006; 42():163-76. PubMed ID: 17144887
[TBL] [Abstract][Full Text] [Related]
11. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
Chalmers L; Kaskel FJ; Bamgbola O
Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
[TBL] [Abstract][Full Text] [Related]
12. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
Chan JC; Tong PC; Critchley JA
Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
[TBL] [Abstract][Full Text] [Related]
13. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.
Jonk AM; Houben AJ; de Jongh RT; Serné EH; Schaper NC; Stehouwer CD
Physiology (Bethesda); 2007 Aug; 22():252-60. PubMed ID: 17699878
[TBL] [Abstract][Full Text] [Related]
14. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.
Correia ML; Rahmouni K
Diabetes Obes Metab; 2006 Nov; 8(6):603-10. PubMed ID: 17026484
[TBL] [Abstract][Full Text] [Related]
15. [Hyperinsulinemia and arterial hypertension].
Kuzmanić D; Jelaković B
Lijec Vjesn; 1996 Mar; 118 Suppl 1():57-61. PubMed ID: 8759412
[TBL] [Abstract][Full Text] [Related]
16. The crosstalk between insulin and the sympathetic nervous system: possible implications in the pathogenesis of essential hypertension.
Lembo G; Vecchione C; Iaccarino G; Trimarco B
Blood Press Suppl; 1996; 1():38-42. PubMed ID: 9162436
[TBL] [Abstract][Full Text] [Related]
17. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
18. Effects of insulin on endothelial and contractile function of subcutaneous small resistance arteries of hypertensive and diabetic patients.
De Ciuceis C; Rizzoni D; Porteri E; Boari GE; Zani F; Miclini M; Tiberio GA; Giulini SM; Paiardi S; Rizzardi N; Platto C; Agabiti-Rosei E
J Vasc Res; 2008; 45(6):512-20. PubMed ID: 18451634
[TBL] [Abstract][Full Text] [Related]
19. Sympathetic overdrive and cardiovascular risk in the metabolic syndrome.
Grassi G
Hypertens Res; 2006 Nov; 29(11):839-47. PubMed ID: 17345783
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance in essential hypertension: a psychophysiological approach to the "chicken and egg" question.
Nazzaro P; Triggiani R; Ciancio L; Scarano AM; Pirrelli AM
Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):275-86. PubMed ID: 11213537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
